Suppr超能文献

幽门螺杆菌在看似成功根除后的复发:随机扩增多态性DNA指纹图谱的新应用

Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting.

作者信息

Xia H X, Windle H J, Marshall D G, Smyth C J, Keane C T, O'Morain C A

机构信息

Department of Clinical Microbiology, St James's Hospital, Dublin, Ireland.

出版信息

Gut. 1995 Jul;37(1):30-4. doi: 10.1136/gut.37.1.30.

Abstract

The aim of this study was to find out if reinfection or recrudescence accounted for the recurrence of Helicobacter pylori infections after apparent eradication of the bacterium. Three hundred and twenty patients were treated with colloidal bismuth subcitrate (120 mg four times daily for four weeks), metronidazole and tetracycline (400 mg and 500 mg, respectively, thrice daily for the first week). H pylori was eradicated four weeks after the end of treatment as assessed by the rapid urease test, histological examination, Gram staining, and culture. However, the infection recurred in 29 (9.1%) of the patients one year after apparent eradication. Pre and posteradication isolates from five patients were available. DNA was extracted and used for restriction endonuclease analysis with Hind III and Hae III, and for polymerase chain reaction (PCR) based randomly amplified polymorphic DNA fingerprinting with a combination of two 10 nucleotide primers. Sodium dodecyl sulphate polyacrylamide gel electrophoretic analysis was performed also. Randomly amplified polymorphic DNA fingerprinting was unique in that it yielded highly discriminatory fingerprints, which showed that the pretreatment and recurrent isolates obtained from each of the five patients were indistinguishable from one another. This shows that recurrence of H pylori infection is probably caused by recrudescence and that the discriminatory power of randomly amplified polymorphic DNA fingerprinting is a practicable and discriminatory typing scheme for H pylori.

摘要

本研究的目的是查明在幽门螺杆菌看似被根除后,再次感染或复发是否是导致其感染复发的原因。320例患者接受了枸橼酸铋胶体(每日4次,每次120毫克,共4周)、甲硝唑和四环素(分别为400毫克和500毫克,第1周每日3次)治疗。治疗结束4周后,通过快速尿素酶试验、组织学检查、革兰氏染色和培养评估,幽门螺杆菌被根除。然而,在看似根除后1年,29例(9.1%)患者的感染复发。有5例患者根除前后的分离株可用。提取DNA并用于Hind III和Hae III的限制性内切酶分析,以及用于基于聚合酶链反应(PCR)的随机扩增多态性DNA指纹分析,使用两种10核苷酸引物的组合。还进行了十二烷基硫酸钠聚丙烯酰胺凝胶电泳分析。随机扩增多态性DNA指纹分析的独特之处在于它产生了高度有鉴别力的指纹,这表明从5例患者中的每例获得的治疗前和复发分离株彼此无法区分。这表明幽门螺杆菌感染的复发可能是由复发引起的,并且随机扩增多态性DNA指纹分析的鉴别力是一种实用且有鉴别力的幽门螺杆菌分型方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70cb/1382763/f93bdcc0ae30/gut00526-0048-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验